Back to Research

Organization profile

MindMaze

MindMaze is a pioneering Swiss neurotechnology company developing AI-driven digital therapeutics and immersive neurorehabilitation solutions to treat neurological diseases and facilitate brain recovery. The company’s integrated platform combines virtual reality, motion tracking, and behavioral protocols to bridge the gap in care between inpatient hospitals and home environments.

Lausanne, SwitzerlandFounded 2012

Overview

1. Executive Summary (Confidence: High)

Founded in 2012 by Tej Tadi, MindMaze is a commercial-stage med-tech leader that has raised approximately USD 224 million to redefine neurorecovery.[7] The company provides a unified ecosystem of evidence-based digital treatments for stroke, Parkinson’s disease, and traumatic brain injury. Its platform, which includes the MindPod Dolphin and MindMotion GO, processes over 1.2 billion data points per month, allowing for precise, AI-personalized therapy.[10] MindMaze has established a first-of-its-kind reimbursement pathway in the US with CPT Category III codes, a strategic move designed to accelerate home-based clinical adoption. With over 40 clinical trials and regulatory clearances globally, MindMaze is positioned to become a dominant player in the digital neurotherapeutics market, which is seeing rapid growth due to global aging trends.[8]

This is an extract of the full organization profile. To access the full company profile, .

Desktop only

Research is currently available on desktop only.

The Research module is designed for larger screens. Please reopen it on a desktop or laptop to use the screener, filters, detail pages, and admin tools.